Nan Fung Trinity (Hk) LTD Verona Pharma PLC Transaction History
Nan Fung Trinity (Hk) LTD
- $910 Million
- Q3 2025
A detailed history of Nan Fung Trinity (Hk) LTD transactions in Verona Pharma PLC stock. As of the latest transaction made, Nan Fung Trinity (Hk) LTD holds 76,320 shares of VRNA stock, worth $8.16 Million. This represents 0.89% of its overall portfolio holdings.
Number of Shares
76,320
Previous 166,620
54.2%
Holding current value
$8.16 Million
Previous $15.8 Million
48.34%
% of portfolio
0.89%
Previous 1.94%
Shares
2 transactions
Others Institutions Holding VRNA
# of Institutions
262Shares Held
78.7MCall Options Held
686KPut Options Held
442K-
Pentwater Capital Management LP Naples, FL5.3MShares$567 Million3.55% of portfolio
-
Ubs Oconnor LLC Chicago, IL4.28MShares$458 Million27.57% of portfolio
-
Hbk Investments L P Dallas, TX4.26MShares$456 Million6.29% of portfolio
-
Fil LTD Hamilton, D03.49MShares$373 Million0.32% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.38MShares$362 Million15.27% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $6.52B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...